Research Reports Initiated on Healthcare Stocks Spectral Medical, GeneNews, Novadaq Technologies, and ProMIS Neurosciences

LONDON, UK / ACCESSWIRE / March 30, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Medical Diagnostics & Research industry. Companies recently under review include Spectral Medical, GeneNews, Novadaq Technologies, and ProMIS Neurosciences. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

On Wednesday, March 29, 2017, at the end of trading session, the Toronto Exchange Composite index ended the day at 15,657.63, 0.38% higher, with a total volume of 316,798,292 shares.

Additionally, the Healthcare index was up by 1.24%, ending the session at 68.69.

Active Wall St. has initiated research reports on the following equities: Spectral Medical Inc. (TSX: EDT), GeneNews Ltd. (TSX: GEN), Novadaq Technologies Inc. (TSX: NDQ), and ProMIS Neurosciences Inc. (TSX: PMN). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Spectral Medical Inc.

Toronto, Canada headquartered Spectral Medical Inc.'s stock plummeted 16.39%, to finish Wednesday's session at $0.51 with a total volume of 1.93 million shares traded. Over the last one month and the previous three months, Spectral Medical's shares have rallied 75.86% and 88.89%, respectively. Shares of the Company, which focuses on the development and commercialization of theranostic treatment for septic shock in North America, are trading above its 50-day and 200-day moving averages. Spectral Medical's 200-day moving average of $0.40 is above its 50-day moving average of $0.32. See our research report on EDT.TO at:

http://www.activewallst.com/register/

GeneNews Ltd.

On Wednesday, shares in Markham, Canada headquartered GeneNews Ltd. recorded a trading volume of 868,897 shares, which was above their three months average volume of 546,451 shares. The stock ended the day 1.35% higher at $0.38. GeneNews' stock has gained 2.70% in the last one month and 26.67% in the previous three months. Furthermore, the stock has rallied 111.11% in the past one year. Shares of the Company, which focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications, are trading above its 50-day moving average. The stock's 200-day moving average of $0.38 is above its 50-day moving average of $0.36. The complimentary research report on GEN.TO at:

http://www.activewallst.com/register/

Novadaq Technologies Inc.

On Wednesday, shares in Mississauga, Canada headquartered Novadaq Technologies Inc. ended the session 0.68% lower at $10.23 with a total volume of 2,400 shares traded. Novadaq Technologies' shares have advanced 6.34% in the last one month and 4.28% in the previous three months. Shares of the Company, which develops, manufactures, and markets fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the US and internationally, are trading above its 50-day moving average. Furthermore, the stock's 200-day moving average of $11.23 is greater than its 50-day moving average of $9.64. Register for free and access the latest research report on NDQ.TO at:

http://www.activewallst.com/register/

ProMIS Neurosciences Inc.

Toronto, Canada headquartered ProMIS Neurosciences Inc.'s stock closed the day 6.90% higher at $0.16. The stock recorded a trading volume of 127,132 shares. ProMIS Neurosciences' shares have rallied 166.67% in the previous one year. Shares of the Company, which discovers and develops therapeutics and diagnostics for the treatment of neurodegenerative diseases in Canada, are trading below their 50-day moving average. Moreover, the stock's 50-day moving average of $0.17 is greater than its 200-day moving average of $0.16. Get free access to your research report on PMN.TO at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street